Evonik Nutrition & Care GmbH will implement price increases for its pharmaceutical excipients and medical device polymers sold under the Eudragit and Resomer brands. This price adjustment is necessary to maintain the high level of service and quality Evonik customers are accustomed to.

Evonik is committed to investments that enhance the quality and availability of supplies and services, exemplified by its increasing network of technical support centres and personnel, which support its customers’ growth.

The nutrition & care segment, led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around €4.2 billion in 2014.

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the nutrition & care, resource efficiency and performance materials segments.